<DOC>
	<DOCNO>NCT02550145</DOCNO>
	<brief_summary>The purpose study evaluate role GLP-1 cause extreme postprandial glucose reduction bariatric surgery subset patient severe symptomatic hypoglycemia .</brief_summary>
	<brief_title>Role GLP-1 Hyperinsulinemic Hypoglycemia Post-bariatric Surgery</brief_title>
	<detailed_description>The physiologic mechanism mediate glucose-lowering effect Roux-en-Y Gastric Bypass ( RYGB ) post-Vertical Sleeve Gastrectomy ( VSG ) unknown . The reduction glucose excursion prior weight loss lead postulate incretin hormone , GLP-1 , may play important role . The purpose study evaluate role GLP-1 cause extreme postprandial glucose reduction subset post-bariatric patient pharmacologic blockade GLP-1 receptor post-RYGB post-VSG patient severe symptomatic hypoglycemia .</detailed_description>
	<mesh_term>Hypoglycemia</mesh_term>
	<criteria>Men woman age 1865 BMI 2540 clinical diagnosis severe symptomatic hypoglycemia bariatric surgery Acute medical illness , acute bacterial viral syndrome , febrile illness , acute abdominal symptom , orthopedic injury within one week History cardiac failure , renal insufficiency ( estimate Crcl &lt; 30cc/min ) , hepatic insufficiency , chronic obstructive pulmonary disease , anemia ( Hct &lt; 30 % ) , uncontrolled hypertension ( SBP &gt; 160 DBP &gt; 100 ) Pregnancy Use medication affect glucose metabolism Fasting glucose &gt; 150 HbA1c &gt; 7.5 Metformin Women childbearing potential ( pregnancy test , addition use abstinence least one month prior study use two type contraceptive , hormonal implant Depo Provera ) Active , uncontrolled psychiatric disease Participating study receive investigational medication within past month 5 halflives drug , whichever longer .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>April 2016</verification_date>
	<keyword>Hyperinsulinemic</keyword>
	<keyword>post-bariatric surgery</keyword>
</DOC>